Cardiovascular Research 2001 51(2):202-204; doi:10.1016/S0008-6363(01)00355-8
© 2001 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Submissions and impact factor 1997–2001: Focus on Sweden
Tobias Opthof*,1,
Ruben Coronel and
Michiel J Janse
Editorial Office of Cardiovascular Research, Academic Medical Center, Room J-127, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
* Corresponding author. Tel.: +31-30-253-8923; fax: +31-30-253-9036 t.opthof{at}med.uu.nl
At the occasion of the congress of the European Society of Cardiology in Stockholm in 2001 we provide our readership with data on the impact factor of Cardiovascular Research and on the submission of manuscripts from different parts of the world.
 |
1 Submissions
|
|---|
In previous editorials we commented on the steady increase in
submissions from Europe during the last decade
[1–3].
Fig. 1 shows that submissions in general continue to increase.
In 1998 the total number exceeded 1000 per year for the first
time. From January 2001 until May 2001 we received over 95 manuscripts
per month, although it was about 60 when we took office in 1995.
A total number well above 1100 is anticipated for 2001.
Fig. 2 shows that the increase in submissions from Europe has stabilized
at about 600 per year, making up about 55% of the total number
(
Fig. 3). From North-America we receive about 24% of the total
number and 21% comes from Japan and the rest of the world, each
making up half of the latter figure. Most manuscripts come from
the the USA (17.5%), followed by the United Kingdom (12.3%),
Germany (11.9%) and Japan (10.6%).
|
2 Impact factor
|
|---|
Fig. 4 shows the official impact factor for
Cardiovascular Research as communicated by the Institute for Scientific Information
(solid line) and our own estimates (dashed line) since 1997.
The last official impact factor for 1999 was 3.09. We predict
an impact factor of 3.59 for the year 2000 and based on data
accumulated between 1 January and 31 May 2001 we expect an impact
factor of 4.85 for the year 2001. The difference between the
solid and dashed lines over the years 1997–1999 give an
impression of the accuracy of our own estimates, although it
should be emphasized that this accuracy only applies to the
prediction for 2000. The prediction for 2001 is based on counts
over the period January–May 2001 with extrapolation to
the end of the year as stated above. Whatever the exact values
will be, we continue to invite our authors to send us their
very best work, because it is obvious that
Cardiovascular Research starts to be successful in bridging the gap with the journals
in the top of the cardiovascular category of the Science Citation
Index
[4,5].
View larger version (21K):
[in this window]
[in a new window]
[Download PowerPoint slide]
|
Fig. 4 Impact factor of Cardiovascular Research over the years 1997–2001. Filled circles and solid line: values of the Institute for Scientific Information. Open circles and dashed line: estimates of the editorial team. Impact factor for 2000 will be communicated in August/September 2001. Impact factor for 2001 will be communicated in August/September 2002.
|
|
Fig. 5 shows the impact factors of individual issues of our
journal since January 1998. The abscissa shows the consecutive
issues with the dates of publication of regular issues and abbreviations
for spotlight issues. The issues on Calcium and Heart Failure
(CAL; February 1998) and Plaque Rupture and Atherosclerosis
(ATH; February 1999) and Molecular Biology of Ion Channels and
Electrical Remodeling (REM; May 1999) were more successful than
the impact factor of the years to which they contributed (dashed
lines) as was the case with spotlight issues in previous years
[6].
View larger version (64K):
[in this window]
[in a new window]
[Download PowerPoint slide]
|
Fig. 5 Impact factor of individual issues of Cardiovascular Research since January 1998. Regular issues are depicted with year and month of publication. Spotlight issues are depicted with the abbreviation of their title. CAL: Calcium and heart failure (February 1998); ANM: Animal models in cardiovascular research (July 1998); END: Endothelins in the cardiovascular system (September 1998); ATH: Plaque rupture and atherosclerosis (February 1999); REM: Molecular biology of ion channels and electrical remodeling (May 1999). The two dashed lines indicate the impact factors of 1999 (3.09) and 2000 (3.59) to which these issues contributed.
|
|
|
3 Manuscripts and reviewers from Sweden
|
|---|
During the last decade about 2.5% of submitted manuscripts came
from Sweden. During the years 1998–2000 reviewers from
Sweden assigned a 34.5% priority to manuscripts on a scale of
0–100% in which 0% indicates a low priority of each of
three reviewers assigned to a manuscript and in which 100% indicates
a high priority of each of three reviewers (
Fig. 6). The difference
with non-Swedish reviewers (35.4%) was not significant. In contrast,
Swedish manuscripts received a priority rating of only 24.3%
on the same 0–100% scale with a 35.7% priority rating
for non-Swedish manuscripts This difference was highly significant
(
P<0.005;
F-test). Interestingly, published Swedish manuscripts,
i.e. after the completion of the review and editorial process,
received a 71% priority score vs. a 66% priority score for non-Swedish
manuscripts, a non-significant difference. Over the years 1992–2000
Swedish manuscripts were cited with a 97±7.0% frequency
compared to the average of the journal.
|
Note added in proof
|
|---|
The Institute for Scientific Information just communicated the
impact factors for the year 2000. The official impact factor
for 2000 is 3.78. The predicted value was 3.59 (see
Fig. 4).
The impact factor of Cardiovasc Res increased by 23.3% from
1999 to 2000.
|
Notes
|
|---|
1 Present address: Department of Medical Physiology, University
Medical Center, P.O. Box 80043, 3508 TA Utrecht, The Netherlands.
See Note added in proof on last page of this Editorial
on behalf of the Editorial Team
|
References
|
|---|
- Opthof T. on behalf of the Editorial Team of Cardiovascular Research. Submissions, publications and reviewers from Europe: focus on Spain. Cardiovasc Res (1999) 43:265–267.[Free Full Text]
- Opthof T., Coronel R., Janse M.J. on behalf of the Editorial Team of Cardiovascular Research. Submissions, editorial process and impact factor 1992–2000: Focus on Europe. Cardiovasc Res (2000) 47:203–206.[Free Full Text]
- Opthof T. on behalf of the Editorial Team of Cardiovascular Research. Geographical shifts in publications. Cardiovasc Res (1999) 42:1–2.[Free Full Text]
- Opthof T., Coronel R., Janse M.J. on behalf of the Editorial Team of Cardiovascular Research. Reviewer's recommendations predict impact: why you have to send us your very best work. Cardiovasc Res (2000) 48:1–3.[Free Full Text]
- Opthof T., Coronel R., Janse M.J. on behalf of the Editorial Team of Cardiovascular Research. Impact factor of Cardiovascular Research in 2000: all time high! Cardiovasc Res (2001) 50:1–2.[Free Full Text]
- Opthof T. on behalf of the Editorial Team of Cardiovascular Research. Submissions, acceptance rate, rapid review system and impact factor. Cardiovasc Res (1999) 41:1–4.[Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
Top
1 Submissions
2 Impact factor
